Upgrade to SI Premium - Free Trial

RBC Reiterates Sector Perform Rating and $22 PT on Depomed (DEPO) Following 4Q Results, Ahead of 2/23 RBC Healthcare Conference

February 22, 2017 7:42 AM
RBC Capital Markets analyst Randall Stanicky reiterates Sector Perform rating and $22 price target on Depomed Inc. (NASDAQ: DEPO), suggesting ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View

Next Articles